Theravance Biopharma Inc. (TBPH)
Market Closed
17 Jul, 20:00
$
16. 93
-0.04
-0.2357%
$
877.45M Market Cap
- P/E Ratio
- Div Yield
449,500 Volume
-0.97 Eps
$ 16.97
Previous Close 
Want to track TBPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.44 | - |
| | | - | - |
| | | 0.67 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.1 | - |
TBPH Earnings Reports FAQ
What is the earnings per share (EPS) for TBPH?
The current EPS is -0.97.
What is the company's earnings growth rate?
Theravance Biopharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Theravance Biopharma Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Theravance Biopharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TBPH at this time, as Theravance Biopharma Inc has no recent EPS data to calculate it.
